Literature DB >> 15280496

Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus.

Jill Douglas1, Bernadette Dutia, Susan Rhind, James P Stewart, Simon J Talbot.   

Abstract

Murid herpesvirus 4 (commonly called MHV-68) is closely related to Kaposi's sarcoma-associated herpesvirus (KSHV) and provides an excellent model system for investigating gammaherpesvirus-associated pathogenesis. MHV-76 is a naturally occurring deletion mutant of MHV-68 that lacks 9,538 bp of the left end of the unique portion of the genome encoding nonessential pathogenesis-related genes. The KSHV K1 protein has been shown to transform rodent fibroblasts in vitro and common marmoset T lymphocytes in vivo. Using homologous recombination techniques, we successfully generated recombinants of MHV-76 that encode green fluorescent protein (MHV76-GFP) and KSHV K1 (MHV76-K1). The replication of MHV76-GFP and MHV76-K1 in cell culture was identical to that of MHV-76. However, infection of BALB/c mice via the intranasal route revealed that MHV76-K1 replicated to a 10-fold higher titer than MHV76-GFP in the lungs at day 5 postinfection (p.i.). We observed type 2 pneumocyte proliferation in areas of consolidation and interstitial inflammation of mice infected with MHV76-K1 at day 10 p.i. MHV76-K1 established a 2- to 3-fold higher latent viral load than MHV76-GFP in the spleens of infected mice on days 10 and 14 p.i., although this was 10-fold lower than that established by wild-type MHV-76. A salivary gland tumor was present in one of four mice infected with MHV76-K1, as well as an increased inflammatory response in the lungs at day 120 p.i. compared with that of mice infected with MHV-76 and MHV76-GFP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280496      PMCID: PMC479053          DOI: 10.1128/JVI.78.16.8878-8884.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.

Authors:  K E Weck; S S Kim; I V Virgin HW; S H Speck
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication.

Authors:  M Lagunoff; D M Lukac; D Ganem
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Murine gamma-herpesvirus-68: a mouse model for infectious mononucleosis?

Authors:  M A Blackman; E Flaño; E Usherwood; D L Woodland
Journal:  Mol Med Today       Date:  2000-12

Review 4.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 5.  Natural history of murine gamma-herpesvirus infection.

Authors:  A A Nash; B M Dutia; J P Stewart; A J Davison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 6.  Dissecting the host response to a gamma-herpesvirus.

Authors:  P C Doherty; J P Christensen; G T Belz; P G Stevenson; M Y Sangster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation.

Authors:  Meagan A Jacoby; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis.

Authors:  A I Macrae; B M Dutia; S Milligan; D G Brownstein; D J Allen; J Mistrikova; A J Davison; A A Nash; J P Stewart
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Characterization of a spontaneous 9.5-kilobase-deletion mutant of murine gammaherpesvirus 68 reveals tissue-specific genetic requirements for latency.

Authors:  Eric T Clambey; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  A broad spectrum secreted chemokine binding protein encoded by a herpesvirus.

Authors:  C M Parry; J P Simas; V P Smith; C A Stewart; A C Minson; S Efstathiou; A Alcami
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  5 in total

1.  Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  Sanjay Chandriani; Don Ganem
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 2.  Cross-regulation between herpesviruses and the TNF superfamily members.

Authors:  John R Sedý; Patricia G Spear; Carl F Ware
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

3.  Epstein-Barr virus IL-10 gene expression by a recombinant murine gammaherpesvirus in vivo enhances acute pathogenicity but does not affect latency or reactivation.

Authors:  Gary J Lindquester; Kimberly A Greer; James P Stewart; Jeffery T Sample
Journal:  Herpesviridae       Date:  2014-09-24

Review 4.  KSHV-Mediated Angiogenesis in Tumor Progression.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Roni Sarkar; Subhash C Verma
Journal:  Viruses       Date:  2016-07-20       Impact factor: 5.048

Review 5.  Kaposi sarcoma herpesvirus pathogenesis.

Authors:  Giuseppe Mariggiò; Sandra Koch; Thomas F Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.